Sahpra’s take on GLP-1 medication use for weight loss in SA.

Loading player...
GUEST: Mokgadi Fafudi – Head of Regulatory Compliance, SAHPRA

As South Africa joins the global weight-loss medication boom, Aspen Pharmacare has just secured approval to market Eli Lilly’s blockbuster drug Mounjaro for chronic weight management. But with growing demand comes growing risk from counterfeit products to off-label use and online scams.

SAHPRA’s Mokgadi Fafudi unpacks what GLP-1 drugs like Ozempic and Mounjaro actually are, how the regulator is responding to the surge in unregistered or fake versions, and what the new approval means for South Africans seeking safe, legitimate weight-loss treatments.
23 Oct 2025 4PM English South Africa Business News · Investing

Other recent episodes

The Business of Art & Auctions

Art may inspire emotion, but it is also a serious business. Following Strauss & Co's latest Johannesburg auction, which delivered more than R52 million in sales and a world auction record for South African artist John Meyer, Executive Director Susie Goodman joins Kaya Biz to explore the economics behind the…
19 Nov 1PM 16 min

SARB November MPC review: Why The SARB Hit Pause

The Reserve Bank has chosen caution over action, but what is the MPC really signalling about South Africa's economic outlook? Economist Tshiamo Masike joins Kaya Biz to unpack the latest interest-rate decision, the battle between inflation and growth, the SARB's evolving focus on credibility and whether further rate cuts remain…
19 Nov 12PM 12 min

Investec’s HY Adjusted Earnings Rise 7.4% As SA Recovery Offsets UK Slump

Investec delivered solid interim results, but the bigger story may lie beyond the numbers. Cumesh Moodliar, CEO of Investec South Africa, joins Kaya Biz to discuss the group's ambitious investment cycle, its push into mid-market banking, technology modernisation, wealth management growth and why management is prepared to spend today to…
19 Nov 12PM 17 min

The Great AI Commoditisation Debate

Nvidia once again delivered blockbuster results, but questions remain about the sustainability of AI spending and where future value will emerge. Gugulethu Mfuphi is joined by Dr Michael Power, independent global strategist and economist, to unpack the battle between open and closed AI models, China's growing influence, the economics of…
18 Nov 12PM 17 min

Southern Sun Hy Profit Jumps 32% On Offshore Profit & SA Occupancy Boom

Southern Sun delivered a strong set of interim results, with revenue, earnings and occupancy all moving higher as travel, conferencing and events activity continued to recover. Marcel von Aulock, CEO of Southern Sun, talks about the drivers behind the group's performance, expansion opportunities, offshore recovery and what hospitality trends reveal…
18 Nov 11AM 15 min